0001100682 1 2026-05-07 2026-05-07 0001100682 2026-05-07 2026-05-07 iso4217:USD pure shares S-8 EX-FILING FEES 0001100682 false N/A S-8 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Equity Common Stock, $0.01 Par Value true 4825000 164.66 794484500.00 0.0001381 109718.31 794484500.00 109718.31 0.00 109718.31 This Registration Statement on Form S-8 (this “Registration Statement”) covers (i) 4,825,000 shares of common stock, $0.01 par value per share (“Common Stock”), of Charles River Laboratories International, Inc., a Delaware corporation (the “Registrant”), available for issuance pursuant to the Charles River Laboratories International, Inc. 2026 Long-Term Incentive Compensation Plan (the “Plan”), and (ii) pursuant to Rule 416(a) under the Securities Act of 1933, as amended, any additional shares of the Common Stock that may become issuable under the Plan by reason of any share dividend, share split, recapitalization or other similar transaction.<br/><br/>The Proposed Maximum Offering Price Per Share is estimated in accordance with Rule 457(c) and (h) solely for purposes of calculating the registration fee on the basis of $164.66, the average of the high and low prices of the Registrant’s Common Stock as reported on the New York Stock Exchange on April 30, 2026, which date is within five business days prior to filing this Registration Statement. The Proposed Maximum Offering Price Per Share, Maximum Aggregate Offering Price and Amount of Registration Fee is rounded up to the nearest penny.